The Analysis of Free Radicals, Lipid Peroxides, Antioxidant Enzymes and Compounds Related to Oxidative Stress as Applied to the Clinical Chemistry Laboratory

  • Donald Armstrong
  • Richard Browne
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 366)


It is almost impossible to read through a medical journal, or even the newspaper and not encounter an article that deals with oxidative stress, or with antioxidant involvement in a disease process. Indeed, free radicals, their reactive intermediates, low molecular weight aldehyde byproducts derived from lipid peroxidation and antioxidant status are important measurements we can utilize to provide a more comprehensive understanding of pathologic mechanisms (1–8). All subcellular organelles normally generate superoxide (O2·-), hydrogen peroxide and a variety of free radicals ie; hydroyl (OH·), perhydroxy(HO2·), carbon and nitrogen centered. It has been estimated that 10 billion of these radicals are produced daily via autoxidation and metabolic reactions. In cellular injury, increased amounts of O2·- radicals and peroxides can arise from the mitochondrial electron-transport system during hypoxia and following reperfusion, they can arise primarily through the activation of NADPH oxidase in phagocyte plasma membranes or from platelet derived endoperoxides of arachidonic acid, from the conversion of xanthine dehydrogenase to xanthine oxidase in tissue and from the generation of OH· radicals in iron-catalyzed reactions involving hemoproteins (9). The most current review by Chaudiere covers theoretical and factual site-specific formation and damage (10).


Lipid Peroxidation Xanthine Oxidase Trolox Equivalent Antioxidant Capacity Diene Conjugation Cholesterol Oxide 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    D. Armstrong, R. Sohol, R. Cutler and T. Slater. “Free Radicals in Molecular Biology, Aging and Disease,” vol. 27, Raven Press, NY, pages 1–416 (1984).Google Scholar
  2. 2.
    C. Hooper, Free Radicals: Research on biochemical bad boys comes of age, J NIH Res 1:101–106 (1989).Google Scholar
  3. 3.
    B. Halliwell, J. Gutteridge and C. Cross, Free radicals, antioxidants and human disease: where are we now, J. Lab. Clin. Med. 119:598–620 (1992).PubMedGoogle Scholar
  4. 4.
    K. Cheeseman, Tissue injury by free radicals, Toxicol. Industrial Health 9:39–51 (1993).Google Scholar
  5. 5.
    K. Yagi. Role of lipid peroxides in aging and age-related diseases, in ““New Trends in Biological Chemistry,” T. Ozawa, ed., Japan Sci. Soc. Press, Tokyo/Springer-Verlag, Berlin, pages 207–242 (1991).Google Scholar
  6. 6.
    E. Stadtman, Protein oxidation and aging, Science 257:1220–1224 (1992).PubMedCrossRefGoogle Scholar
  7. 7.
    E. Harris, Regulation of antioxidant enzymes, The FASEB Journal 6:2675–2683 (1992).Google Scholar
  8. 8.
    A. Baouali, H. Aube, V. Maupoil, et al, Plasma lipid peroxidation in critically ill patients: importance of mechanical ventilation, Free Rad. Biol. Med. 16: 223–227 (1994).PubMedCrossRefGoogle Scholar
  9. 9.
    J. McCord and B. Omar, Sources of free radicals, Toxicol. Industrial Health 9: 23–37 (1993).Google Scholar
  10. 10.
    J. Chaudiere, Some chemical and biochemical constraints of oxidative stress in living cells, in “Free Radical Damage and its Control,” C. Rice-Evans and R. Burden eds., New Comprehensive Biochemistry, Elsevier Biomedical Press, Amsterdam, pages 24–64 (1994).Google Scholar
  11. 11.
    S. Liochev and J. Fridovich, The role of O2•— in the production of HO in vitro and in vivo, Free Rad. Biol. Med. 16: 29–33 (1994).PubMedCrossRefGoogle Scholar
  12. 12.
    K. Yagi, N. Ishida, S. Komura, et al, Generation of hydroxyl radical from linoleic acid hydroperoxide in the presence of epinephrine and iron, Biochem. Biophys. Res. Comm. 183:945–951 (1992).PubMedCrossRefGoogle Scholar
  13. 13.
    M. Stampfer, C. Hennekens, J. Manson, et al, Vitamin E consumption and the risk of coronary disease in women, NEJM 328:1444–1449 (1993).PubMedCrossRefGoogle Scholar
  14. 14.
    E. Rimm, M. Stampfer, A. Ascherio, et al, Vitamin E consumption and the risk of coronary disease in men, NEJM 328:1450–1456 (1993).PubMedCrossRefGoogle Scholar
  15. 15.
    T. Emerson, Unique features of albumin: a brief review, Crit. Care Med. 17:690–694 (1989).PubMedCrossRefGoogle Scholar
  16. 16.
    R. Pirisino, P. DiSimplicio, G. Ignesti, et al, Sulfhydryl group and peroxidase-like activity of albumin as scavenger of organic peroxides, Pharmacol. Res. Commun. 20:545–552 (1988).PubMedCrossRefGoogle Scholar
  17. 17.
    T. Suematsu, T. Kamada, H. Abe, et al, Serum lipoperoxide level in patients suffering from liver disease, Clin. Chem. Acta. 79:267–270 (1977).CrossRefGoogle Scholar
  18. 18.
    K. Satoh, Serum lipid peroxide in cerebrovascular disorders determined by a new colorimetrie method, Clin. Chem. Acta. 90:37–43 (1987).Google Scholar
  19. 19.
    M. Santos, J. Vales, J. Angar, et al, Determination of plasma malondialdehyde-like material and its clinical application in stroke patients, J. Clin. Pathol. 33:973–976 (1980).PubMedCrossRefGoogle Scholar
  20. 20.
    M. Maseki, J. Nishigaki, M. Hagihara, et al Lipid peroxide levels and lipid content of serum lipoprotein fractions of pregnant subjects with or without pre-eclampsia, Clin. Chem. Acta. 115:155–161 (1981).CrossRefGoogle Scholar
  21. 21.
    J. Anzar, M. Santos, J. Valles, et al, Serum malondialdehyde-like material (MDA-LM) in acute myocardial infarction, J. Clin. Pathol. 36:312–715 (1983).CrossRefGoogle Scholar
  22. 22.
    S. Wong, J. Knight, S. Hopfer, et al, Lipoperoxides in plasma as measured by liquid-chromatographic separation of malondialdehyde-thiobarbituric acid adduct, Clin. Chem. 33:214–220 (1987).PubMedGoogle Scholar
  23. 23.
    J. Knight, E. Smith, V. Kinder, et al, Reference intervals for plasma lipoperoxides: Age, sex and specimen-related variations, Clin. Chem. 33:2289–2291 (1987).PubMedGoogle Scholar
  24. 24.
    J. Knight, R. Pieper, S. Smith et al, Increased urinary lipoperoxides in drug abuses, Ann. Clin. Lab. Sci. 18:374–377 (1988).PubMedGoogle Scholar
  25. 25.
    J. Knight, R. Pieper and L. McClellan, Specificity of the thiobarbituric acid reaction: Its use in studies of lipid peroxidation, Clin. Chem. 34:2433–2438 (1988).PubMedGoogle Scholar
  26. 26.
    J. Knight, A. Cheung, R. Pieper et al, Increased urinary lipoperoxide levels in renal transplant patients, Ann. Clin. Lab. Sci., 19:238–241 (1989).PubMedGoogle Scholar
  27. 27.
    E. Zarling and M. Clapper, Technique for gas-chromatographic measurement of volatile alkanes from single-breath samples, Clin. Chem. 33:140–141 (1987).PubMedGoogle Scholar
  28. 28.
    J. Knight,. McClellan and J. Stabell, Cerebrospinal fluid lipoperoxides quantified by liquid chromatography and determination of reference values, Clin. Chem. 36:139–142 (1990).PubMedGoogle Scholar
  29. 29.
    F. van Kuijk, D. Thomas, J. Konopelski et al, Transesterification of phospholipids or triglycerides to fatty acid benzyl esters with simultaneous methylation of free fatty acids for gas-liquid chromatographic analysis, J. Lipid Res, 27:452–456 (1986).PubMedGoogle Scholar
  30. 30.
    M. Selley, M. Bartlett, J. McGuiness, et al, Determination of the lipid peroxidation product trans-4-hydroxy-2-nonenal in biological samples by high performance liquid chromatography and combined capillary column gas chromatography-negative-ion chemical ionization mass spectroscopy, J. Chromatogr., 488:329–340 (1989).PubMedCrossRefGoogle Scholar
  31. 31.
    V. Sharov, V. Kazamanov, and Y. Vladimirov, Selective sensitization of chemiluminescence resulting from lipid and oxygen radical reactions, Free Rad. Biol. Med 7:237–242 (1989).PubMedCrossRefGoogle Scholar
  32. 32.
    I. Minkenberg and E. Ferber, Lucigenin-dependent chemiluminescence as a new assay for NADPH oxidase activity in particulate practices of human polymorphonuclear leukocytes, J. Immunol. Meth., 71:61–68 (1984).CrossRefGoogle Scholar
  33. 33.
    M. Tosi and A. Hamedeni, A rapid, specific assay for superoxide release from phagocytes in small volumes of whole blood, Am. J. Clin. Pathol., 97:566–573 (1992).PubMedGoogle Scholar
  34. 34.
    M. Nakano, Determination of superoxide radical and singlet oxygen based on chemiluminescence of Luciferin analogs, in “Oxygen Radicals in Biological Systems”, Methods of Enzymology, vol. 186, L. Packer, and A. Glacer, eds., Academic Press, San Diego, CA, pages 585–591 (1990).Google Scholar
  35. 35.
    T. Miyazawa, Determination of phospholipid hydroperoxides in human blood plasma by a chemiluminescence-HPLC assay, Free Rad. Biol. Med. 7:209–217 (1989).PubMedCrossRefGoogle Scholar
  36. 36.
    T. Nicotera, K. Thusa, and P. Dandona, Elevated production of active oxygen in Bloomus syndrome cell lines, Cancer Res. 53:5104–5107 (1993).PubMedGoogle Scholar
  37. 37.
    T. Mizawa, K. Fujimoto and S. Oikawa, Determination of lipid hydroperoxides in low density lipoprotein from human plasma using high performance liquid chromatography with chemiluminescence detection, Biomed. Chromatogr. 4:131–134 (1990).CrossRefGoogle Scholar
  38. 38.
    W. Davis, B. Mohammad, D. Mays, et al, Hydroxylation of salicylate by activated neutrophils, Biochem. Pharmacol. 38:4013–4019 (1989).PubMedCrossRefGoogle Scholar
  39. 39.
    B. Halliwell, H. Kaur and M. Ingelman-Sundberg, Hydroxylation of salicylate as an assay for hydroxyl radicals: a cautionary note, Free Rad. Biol. Med. 10:439–441 (1991).PubMedCrossRefGoogle Scholar
  40. 40.
    A. Ghiselli, O. Laurenti, G. DeMattia, et al, Salicylate hydroxylation as an early marker of in vivo oxidative stress in diabetic patients, Free Rad. Biol. Med. 13:621–626 (1992).PubMedCrossRefGoogle Scholar
  41. 41.
    F. Corongiu and A. Milia, An improved and simple method for determining diene conjugation in autoxidized polyunsaturated fatty acids, Chem.-Biol. Interactions 44:289–297 (1983).CrossRefGoogle Scholar
  42. 42.
    D. Armstrong, T. Hiramitsu, J. Gutteridge, et al, Studies on experimentally induced retinal degeneration, I. Effect of lipid peroxides on electroretinographic activity in the albino rabbit, Exp. Eye Res. 35:157–171 (1982).PubMedCrossRefGoogle Scholar
  43. 43.
    G. Metz, M. Gassull, A. Leeds, et al, A simple method of measuring hydrogen in carbohydrate malabsorption by end-expiratory sampling, Clin. Sci. Mol. Med. 50:237–240 (1976).PubMedGoogle Scholar
  44. 44.
    K. Yagi, A simple fluorometric assay for lipoperoxide in blood plasma, Biochem. Med. 15:212–216 (1976).PubMedCrossRefGoogle Scholar
  45. 45.
    D. Janero, Malondialdehyde and thiobarbituric acid-reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury, Free Rad. Biol. Med. 9:515–540 (1990).PubMedCrossRefGoogle Scholar
  46. 46.
    A. Valenzuela, The biological significance of malondialdehyde determination in the assessment of tissue oxidative stress, Life Sci. 48:301–309 (1991).PubMedCrossRefGoogle Scholar
  47. 47.
    D. Armstrong, N. Abdella, A. Salman, et al, Relationship of lipid peroxides to diabetic complications: comparison with conventional laboratory tests, J. Diab. Comp. 6:116–122 (1992).CrossRefGoogle Scholar
  48. 48.
    D. Armstrong and F. Al-Awadi, Lipid peroxidation and retinopathy in streptozotorin-induced diabetes, Free Rad. Biol. Med. 11:433–436 (1991).PubMedCrossRefGoogle Scholar
  49. 49.
    M. Conti, P. Morand, P. Levillain, et al, Improved fluorometric determination of malondialdehyde, Clin. Chem. 37:1273–1275 (1991).PubMedGoogle Scholar
  50. 50.
    H. Ikatsu, T. Nakajima, N. Murayama, et al, Flow-injection analysis for malondialdehyde in plasma with the thiobarbituric acid reaction, Clin. Chem. 38:2061–2065 (1992).PubMedGoogle Scholar
  51. 51.
    A. Miiki, N. Kayahara, Y. Yokote, et al, A simple assay for lipid peroxides using a leucomethylene blue derivative, Clin. Chem. 34:1228 (1988).Google Scholar
  52. 52.
    A. Yalcin, G. Haklar and K. Emerk, Simple colorimetric method for determination of peroxide, Clin. Chem. 39:2534–2535 (1993).PubMedGoogle Scholar
  53. 53.
    C. Smith, M. Mitchinson and B. Hallwell, Lipid peroxidation in hyperlipidaemic patients. A study of plasma using an HPLC-based thiobarbituric acid test, Free Radic. Res. Comm. 19:51–57 (1993).CrossRefGoogle Scholar
  54. 54.
    H. Draper, E. Squires, H. Mahmoodi, et al, A comparison evaluation of thiobarbituric acid methods for the determination of malondialdehyde in biological materials, Free Rad. Biol. Med. 15:353–363 (1993).PubMedCrossRefGoogle Scholar
  55. 55.
    A. Holley, M. Walker, K. Cheeseman, et al, Measurement of n-alkanals and hydroxyalkanals in biological samples, Free Rad. Biol. Med. 15:281–289 (1993).PubMedCrossRefGoogle Scholar
  56. 56.
    V. Bowry, K. Stanley and R. Stocker, High density lipoprotein is the major carrier of lipid hydroperoxides in human blood plasma from fasting donors, Proc. Natl. Acad. Sci. 89:10316–10320 (1992).PubMedCrossRefGoogle Scholar
  57. 57.
    J. Salonen, S. Yla-Herttula, R. Yamamota, et al, Autoantibody against oxidized LDL and progression of carotid atherosclerosis, The Lancet 339:883–887 (1992).CrossRefGoogle Scholar
  58. 58.
    H. Hoff, J. O’Neil, G. Chisolm, et al, Modification of low density lipoprotein with 4-hydroxynonenal induces uptake by macrophages, Arteriosclerosis 9:538–549 (1989).PubMedCrossRefGoogle Scholar
  59. 59.
    B. Kalyanaraman, W. Antholine and S. Parthasarathy, Oxidation of lowdensity lipoprotein by Cu2+ and lipoxygenase: an electron spin resonance study, Biochem. Biophys. Acta 1035:286–292 (1990).PubMedCrossRefGoogle Scholar
  60. 60.
    H. Kleinveld, H. Hak-Lemmers, A. Stalenhoef, et al, Improved measurement of low-density-lipoprotein susceptibility to copper-induced oxidation: application of a short procedure for isolating low-density lipoprotein, Clin. Chem. 38:2066–2072 (1992).PubMedGoogle Scholar
  61. 61.
    W. Palinski, S. Yla-Herttuala, M. Rosenfeld, et al, Antisera and monoclonal antibodies specific for epitopes generated during oxidative modification of low density lipoprotein, Arteriosclerosis 10:325–335 (1990).PubMedCrossRefGoogle Scholar
  62. 62.
    B. Frei, Y. Yamamota, D. Niclas, et al, Evaluation of an isoluminol chemiluminescence assay for the detection of hydroperoxides in human plasma, Anal. Biochem. 175:120–130 (1988).Google Scholar
  63. 63.
    H. Kleinveld, A. Naker, A. Stalenhoef, et al, Oxidation resistance, oxidation rate and extent of oxidation of human low-density lipoprotein depend on the ratio of oleic acid content to linoleic acid content: studies in vitamin E deficient subjects, Free Rad. Biol. Med. 15:273–280 (1993).PubMedCrossRefGoogle Scholar
  64. 64.
    J. Teare, N. Punchard, J. Powell, et al, Automated spectrophotometric method for determining oxidized and reduced glutathione in liver, Clin. Chem. 39:686–689 (1993).PubMedGoogle Scholar
  65. 65.
    P. Hissin and R. Hilf, A fluorometric method for determination of oxidized and reduced glutathione in tissues, Anal. Biochem. 74:214–226 (1976).PubMedCrossRefGoogle Scholar
  66. 66.
    J. Richie and C. Lang, The determination of glutathione, cyst (e) ine and other thiols and disulfides in biological samples using high-performance liquid chromatography with dual electrochemical detection, Anal. Biochem. 163:9–15 (1987).PubMedCrossRefGoogle Scholar
  67. 67.
    J. Gutteridge, D. Rowley, E. Griffiths, et al, Low-molecular-weight iron complexes and oxygen radical reactions in idiopathic hemochromatosis, Clinical Science 68:463–467 (1985).PubMedGoogle Scholar
  68. 68.
    O. Aruma, A. Bomford, R. Poison, et al, Non-tranfonon-bound iron in plasma from hemochromatosis patients: effect of phlebotomy therapy, Blood 72:1416–1419 (1988).Google Scholar
  69. 69.
    B. Halliwell, O. Aruma, G. Maefi, et al, Bleomycin-detectable iron in serum from leukaemic patients before and after chemotherapy, FEBS Letters 241:202–204 (1988).PubMedCrossRefGoogle Scholar
  70. 70.
    M. Grootveld, J Bell, b. Halliwell, et al, Non-transferrin-bound iron in plasma or serum from patients with idiopathic hemochromatosis. Characterization by high performance liquid chromatography and nuclear magnetic resonance spectroscopy, J. Biol. Chem. 264:4417–4422 (1989).PubMedGoogle Scholar
  71. 71.
    M. Richard, J. Arnaud, C. Jurkovitz, et al, Trace elements and lipid peroxidation abnormalities in patients with chronic renal failure, Nephron 57:10–15 (1991).PubMedCrossRefGoogle Scholar
  72. 72.
    A. Alfthan, A micromethod for the determination of selenium in tissues and biological fluids by single-test-tube fluorimetry, Anal. Chem. Acta 165:187–194 (1984).CrossRefGoogle Scholar
  73. 73.
    Z. Zaman, P. Fielden and P. Frost, Simultaneous determination of Vitamin A and E and carotenoids in plasma by reversed-phase HPLC in elderly and younger subjects, Clin. Chem. 39:2229–2234 (1993).PubMedGoogle Scholar
  74. 74.
    N. Miller, J. Shatti and C. Rice-Evans, Plasma vitamin C analysis by the ferrozine method using the Cobas Mira analyzer, (personal communication).Google Scholar
  75. 75.
    S. Umeki, M. Sumi, Y. Niki, et al, Concentrations of superoxide dismutase and superoxide anion in blood of patients with respiratory infection and compromised immune systems, Clin. Chem. 33:2230–2233 (1987).PubMedGoogle Scholar
  76. 76.
    J. Crapo, T. Oury, C. Rahouille, et al, Copper, zinc superoxide dismutase is primarily a cytosolic protein in human cells, Proc. Natl. Acad. Sci. 89:10405–10409 (1992).PubMedCrossRefGoogle Scholar
  77. 77.
    D. Newsome, E. Dohard, M. Liles, et al, Human retinal pigment epithelium contains two distinct species of superoxide dismutase, Invest. Ophthalmol. Vis. Sci. 31:2508–2513 (1990).PubMedGoogle Scholar
  78. 78.
    N. Miller, C. Rice-Evans, M. Davies, et al, A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates, Clin. Sci. 84:407–412 (1993).PubMedGoogle Scholar
  79. 79.
    G. Cao, H. Alessio and R. Cutter, Oxygen-radical absorbance capacity assays for antioxidants, Free Rad. Biol. Med. 14:303–311 (1993).PubMedCrossRefGoogle Scholar
  80. 80.
    M. Arshad, S. Bhadra, R. Cohen, et al, Plasma lipoprotein peroxidation potential: a test to evaluate individual susceptibility to peroxidation, Clin. Chem. 37:1756–1758 (1991).PubMedGoogle Scholar
  81. 81.
    M.-J. Richard, B. Portal, J. Meo, et al, Malondialdehyde kit evaluated for determining plasma and lipoprotein fractions that react with thiobarbituric acid, Clin. Chem. 38:704–709 (1992).PubMedGoogle Scholar
  82. 82.
    C. Nebot, M. Moutet, P. Huet, et al, Spectrophotometric assay of superoxide dismutase activity based on the activated autoxidation of a tetracyclic catechol, Anal. Biochem. 214:442–451 (1993).PubMedCrossRefGoogle Scholar
  83. 83.
    P.E. Jennings, N.A. Scott, A.R. Saniabadi, et al, Effects of gliclazide on platelet reactivity and free radicals in type II diabetic patients: clinical assessment, Metabolism 41:36–39 (1992)PubMedCrossRefGoogle Scholar
  84. 84.
    B. Halliwell and J. Gutteridge, The antioxidants of human extracellular fluids, Arch. Biochem. Biophys. 280:1–8 (1990).PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1994

Authors and Affiliations

  • Donald Armstrong
    • 1
  • Richard Browne
    • 1
  1. 1.Department of Clinical Laboratory ScienceUniversity at BuffaloBuffaloUSA

Personalised recommendations